NM_024649.5:c.1762G>A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_024649.5(BBS1):c.1762G>A(p.Glu588Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,606,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024649.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBS1 | ENST00000318312.12 | c.1762G>A | p.Glu588Lys | missense_variant | Exon 17 of 17 | 1 | NM_024649.5 | ENSP00000317469.7 | ||
ENSG00000256349 | ENST00000419755.3 | c.1873G>A | p.Glu625Lys | missense_variant | Exon 17 of 17 | 2 | ENSP00000398526.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000254 AC: 6AN: 236526Hom.: 0 AF XY: 0.0000156 AC XY: 2AN XY: 127986
GnomAD4 exome AF: 0.00000687 AC: 10AN: 1454790Hom.: 0 Cov.: 38 AF XY: 0.0000111 AC XY: 8AN XY: 723266
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74290
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 1 Uncertain:2
- -
- -
Inborn genetic diseases Uncertain:1
The c.1762G>A (p.E588K) alteration is located in exon 17 (coding exon 17) of the BBS1 gene. This alteration results from a G to A substitution at nucleotide position 1762, causing the glutamic acid (E) at amino acid position 588 to be replaced by a lysine (K). The p.E588K alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Bardet-Biedl syndrome Uncertain:1
This sequence change replaces glutamic acid with lysine at codon 588 of the BBS1 protein (p.Glu588Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This missense change has been observed in individual(s) with clinical features of BBS1-related conditions (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at